ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 143,300
+2,200 (1.56%)
Apr 10, 2026, 3:30 PM KST
ST Pharm Market Cap
ST Pharm has a market cap or net worth of 2.94 trillion as of April 10, 2026. Its market cap has increased by 92.89% in one year.
Market Cap
2.94T
Enterprise Value
2.93T
Revenue
331.68B
Ranking
n/a
PE Ratio
52.49
Stock Price
143,300.00
Market Cap Chart
Since June 23, 2016, ST Pharm's market cap has increased from 902.04B to 2.94T, an increase of 225.80%. That is a compound annual growth rate of 12.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 2.94T | 19.10% |
| Dec 30, 2025 | 2.47T | 37.85% |
| Dec 30, 2024 | 1.79T | 40.37% |
| Dec 28, 2023 | 1.28T | -22.60% |
| Dec 29, 2022 | 1.65T | -36.55% |
| Dec 30, 2021 | 2.60T | 34.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.97T |
| Celltrion | 44.18T |
| ALTEOGEN | 20.04T |
| Samsung Epis Holdings | 12.86T |
| OliX Pharmaceuticals | 3.33T |
| SK bioscience | 3.27T |
| PharmaResearch | 3.06T |
| D&D Pharmatech | 3.04T |